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Phosphatidic acidEndothelial permeability is controlled by adhesive strengths which connect cells to each other through
interendothelial junctions and by contractile forces associated with cytoskeleton reorganization. Phospho-
lipase D (PLD) activation resulting in the generation of phosphatidic acid (PA) is increasingly recognized as a
key event in the initiation of various cell responses. In human umbilical vein endothelial cells (HUV-EC),
enhancement of intracellular PA by a variety of approaches increased the permeability of endothelial cell
monolayers and induced stress ﬁbre formation. Using adenovirus-mediated overexpression and siRNA
silencing, we showed that PLD2 but not PLD1 was involved in the enhancement of basal permeability
through cytoskeleton reorganization. Furthermore, PLD2 overexpression induced ERK1/2 activation and
downregulated the expression of occludin, a major component of tight junctions. A substantial part of PLD2
protein was associated with the low-density caveolin-rich fractions isolated on sucrose gradients. The Raf-1
speciﬁc inhibitor GW-5074 drastically reduced hyperpermeability induced by PLD2 overexpression, and
inhibited PA-mediated increase of endothelial permeability and ERK1/2 activation. On the whole, the present
results demonstrate the selective role of PLD2 isoform in the control of endothelial permeability through a
mechanism involving both stress ﬁbre formation and contraction, and occludin downregulation, possibly
resulting from PA-mediated activation of Raf-1.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Endothelial cells (ECs) form a semipermeable dynamic barrier that
regulates the exchange of ﬂuids and solutes between the vascular
space and underlying tissues, and controls protein ﬂux between the
blood and subendothelial compartments [1,2]. Disruption of this semi-
selective barrier is a hallmark of several pathological conditions
including inﬂammation, atherosclerosis and tumor angiogenesis. The
barrier function of endothelial monolayers results from an equilibrium
between adhesive strengths which connect ECs to each other via a
complex set of junctional proteins and to the extracellular matrix
(ECM) proteins via integrins, and contractile forces. Generation of
contractile forces within endothelial cells can open intercellular gaps,
and thus alter the barrier properties of the monolayer. Indeed, earlier
reports have clearly established direct relationships between
increased permeability and endothelial contraction leading to cell5, Faculté de Médecine Lyon-
oz).
ll rights reserved.retraction [2 for review]. Endothelial contraction is associated with an
extensive rearrangement of actin microﬁlaments from a circumfer-
ential ring to stress ﬁbres composed of bundles of polymerized actin
and myosin ﬁlaments [3]. It is now well-recognized that vascular
permeability is directly controlled by cytoskeleton rearrangements
involving the formation of stress ﬁbres.
On the other hand, increasing evidence suggests that lipid raft and
caveolae membrane domains play an important role in the regulation
of membrane–cytoskeleton interactions [4]. Several cytoskeleton
modulators such as phosphatidylinositol 4,5-bisphosphate (PI4,5P2)
or Rho GTPases, and cytoskeletal proteins such as actin and vimentin
are associatedwith rafts [5]. In epithelial cells, the structural protein of
tight junctions occludin, and the peripheral membrane protein ZO-1
that links tight junctions to actin cytoskeleton, have been found in the
detergent insoluble fractions constituting raft microdomains whereas
other transmembrane proteins such as E-cadherin and beta-1 integrin
were not enriched in these structures. In addition, part of occludin
pool co-immunoprecipitated with caveolin-1 [6]. Interestingly, phos-
pholipase D (PLD) which is also involved in the regulation of
cytoskeleton dynamics [7] has been described as associated to lipid
rafts [8]. This enzyme which hydrolyzes phosphatidylcholine to
Fig. 1. Effects of LPA and S1P on PLD activity and permeability of HUV-EC. Panel A, [3H]
labelled HUV-EC were incubated with 10 μM LPA or 1 μM S1P for the indicated period of
time, in the presence or absence of 1% 1-butanol added 30 min before the end of each
treatment. Lipids were then extracted as described in Materials and methods. The
radioactivity of phosphatidylbutanol was expressed as percent of total phospholipid
radioactivity. Results are means±SEM of N=3 separate experiments. ⁎, signiﬁcantly
different from time 0, Pb0.05. Panel B, HUV-EC monolayers were treated with 10 μM
LPA for the indicated period of time. HRP was added simultaneously at the beginning of
experiments. Results are expressed as fold increase compared with the value for control
cells at each time point and are means±SEM of N=6 separate experiments performed
in quadruplicate. ⁎, signiﬁcantly different from control cells, Pb0.05. Panel C, HUV-EC
were treated with 1 μM S1P as described above. Results are means±SEM of N=3
separate experiments performed in quadruplicate. ⁎, signiﬁcantly different from control
cells, Pb0.05; †, signiﬁcantly different from 1 h time point, Pb0.05.
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or PLD2, or both isoenzymes have been found in raft domains
depending on the type of cell considered. Thus, Yoon et al. [9] have
reported the presence of both PLD1 and PLD2 in the caveolin-1
enriched fractions isolated from primary human umbilical vein
endothelial cells (HUV-EC),whereas Cho et al. [10] only detected PLD2.
Most vasoactive agents which have been shown to induce
endothelial permeability [2] are able to stimulate endothelial
phospholipase D (PLD). Thus, thrombin treatment of primary HUV-
EC potently increases the PLD activity in a time- and dose-dependent
fashion [11]. Similarly, histamine has been shown to dose-depen-
dently increase the PLD activity of human aortic endothelial cells [12]
and bradykinin proved to be an effective PLD activator in bovine
pulmonary aortic endothelial cells [13]. Reactive oxygen species (ROS)
generated in the vasculature by activated neutrophils or vascular cells
have also been implicated in increased endothelium permeability
leading to barrier dysfunction. Interestingly, ROS have also been
shown to stimulate PLD activity in several cell types including
endothelial cells [14,15].
A role for PLD and its product PA has been postulated in the
regulation of actin cytoskeleton. The ﬁrst observations that exogenous
PA or lysophosphatidic acid (LPA)-induced PLD activation induced
actin polymerization were made by Exton's group in HC9 ﬁbroblasts
[16,17]. The fact that LPA-induced PA generation and stress ﬁbre
formation were both inhibited by 1-butanol, and not by 2-butanol,
suggested that PLD can control cytoskeletal reorganization. Similar
results were obtained later by Cross et al. [18] using porcine aortic
endothelial cells and by Porcelli et al. [19] in human airway epithelial
cells. Partial inactivation of PLD1 by stable expression of a dominant
negative mutant for rPLD1 markedly reduced LPA effects on both PLD
activation and stress ﬁbre formation [20]. At variance with the above
results Su et al. [21] reported that PLD1 depletion of HeLa cells by
shRNA or tetracycline-induced overexpression of PLD1 in CHO cells
did not alter the number of spontaneously formed stress ﬁbres.
However, the authors did not examine the possible role of PLD2.
To test the hypothesis that one or the other PLD isoform is an
important regulator of endothelial permeability we examined the
inﬂuence of changes in PLD expression or changes in intracellular PA
levels on endothelial permeability and actin cytoskeleton organization,
using a HUV-EC cell line. Our results show that enhancement of intra-
cellular PA increases endothelial permeability and that PLD2 is more
speciﬁcally involved in the regulation of basal endothelial permeability
presumably due to its preferential localization into lipid rafts. Mechan-
istically, our observations suggest that PLD2 dependent increased
endothelial permeability is linked to both PA-dependent cytoskeleton
rearrangement and activation of the Raf-MEK-ERK1/2 signaling path-
way which negatively regulates the expression level of occludin.
2. Materials and methods
2.1. Materials
Triton X-100 was from Pierce. Silica Gel G60 TLC plates were from
VWR International (Fontenay sous-Bois, France). [3H]-palmitic acid
was from Perkin Elmer Life Sciences. [3H]5′-AMP (speciﬁc activity
722 GBq/mmol), MP Hyperﬁlm, ECL were from GE Healthcare Life
Sciences (Orsay, France). HRP-conjugated anti-mouse IgG antibody
was from Jackson Immunoresearch Laboratories (Soham, UK).
Bradford protein assay and HRP-conjugated anti-rabbit IgG antibody
were from Bio-Rad (Marnes-La-Coquette, France). Anti-occludin,
antibody was from Zymed (Invitrogen, Cergy Pontoise, France). Anti
pERK (sc-7383) antibody (Santa Cruz Biotechnology), compounds U-
0126 and PD98059 were from TEBU (Le Perray-en-Yvelines, France).
Immobilon P membranes were from Millipore (St Quentin-en-
Yvelines, France). Endothelial cell growth factor, ﬁbronectin, phos-
pholipase D from Streptomyces chromofuscus, L-α dioctanoyl phos-phatidic acid and egg yolk phosphatidic acid (sodium salts), L-α-
oleyl-lysophosphatidic acid, sphingosine-1 phosphate (S1P), ﬁlipin,
raf-1 inhibitor GW 5074, anti α-tubulin monoclonal antibody, horse-
radish peroxydase, PLD1 and PLD2 siRNA were from Sigma-Aldrich
(L'Isle d'Abeau, France). Negative control siRNA was from Eurogentec
(Angers, France). PLD1- and PLD2-speciﬁc polyclonal antibodies were
kindly provided by Dr S. Bourgoin (Laval University, Canada).
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Human umbilical vein endothelial cell line (HUV-EC, CRL-1730)
and human embryonic kidney cell line (HEK 293) were obtained
from American Type Culture Collection (Rockville, MD). HUV-EC
cells were maintained in Ham's F12K medium containing 10% (vol/
vol) foetal calf serum, 2.5 g/l sodium bicarbonate, 100 U/ml
penicillin, 100 μg/ml streptomycin and 1 ml/100 ml culture medium
of endothelial cell growth factor, in 5% CO2 at 37 °C in a humidiﬁed
incubator. Treatments were carried out on 100% conﬂuent cells. For
adenoviral ampliﬁcation, HEK 293 cells were maintained in DMEM
containing 5% (vol/vol) foetal calf serum, 100 U/ml penicillin, and
100 μg/ml streptomycin.
2.3. PLD assay in intact HUV-EC
PLD activity was determined on the basis of its transphosphatidy-
lation activity. Cells were labelled in serum-free medium containing
2 μCi/ml [3H]palmitic acid for 2 h at 37 °C. Cells were then washed
twice with PBS and treated for the indicated times with LPA and S1P.
Butan-1-ol (1% ﬁnal concentration) was added 30 min before the end
of each treatment. Cells were then collected and lipids extracted by
the method of Bligh and Dyer [22] in the presence of 50 μM
butylhydroxylated toluene. Phosphatidylbutanol was separated by
bidimensional TLC using chloroform/methanol/28% ammonia
(65:35:5.5, by volume) for the ﬁrst migration, and ethyl acetate/
isooctane/acetic acid (9:5:2, by volume) for migration in the second
dimension. TLC plates were then stainedwith Coomassie Brilliant Blue
R, phosphatidylbutanol spots were scraped off and the radioactivity
determined by liquid scintillation counting. Radioactivity associated
with phosphatidylbutanol was expressed as percentage of total
phospholipid radioactivity.Fig. 2. Effects of increased endogenous PA level on HUV-EC permeability. HUV-EC monolayer
(panel C) 50 μMdi-C8 PA. HRPwas added simultaneously with drugs at the beginning of expe
at each time point and are means±SEM of N=3 (panels A and B) or N=4 (panel C) separa
Pb0.05.2.4. Measurement of paracellular permeability
The HRP ﬂux which reﬂects the paracellular permeability was
measured according to the procedure of Hirase et al. [23] with slight
modiﬁcations. Brieﬂy, HUV-EC were seeded onto 0.4 μm polycarbo-
nate Transwell ﬁlters (BD Falcon) coated with 5 μg/ml ﬁbronectin.
Conﬂuent cells were incubated in serum-freemedium for 2–3 h before
treatment. Resistance of HUV-EC monolayers was measured using
Milicell Electrical Resitance System (Millipore) at the beginning of the
experiments to verify that the permeability was equivalent for each
Transwell system. Then, cells were incubated with the different
agonists, in presence or absence of inhibitors, for the indicated periods
of time. HRP dissolved in sterile water to give a ﬁnal concentration of
35 μM was added simultaneously with drugs in the upper compart-
ment at the beginning of experiment. The upper and lower chambers
contained 1.5 ml and 3 ml of serum-free medium, respectively (6-well
system) or 1 ml and 2 ml (12-well system). 30 min, 1 h, 2 h, 4 h and
24 h after HRP addition, 100 μl of medium was collected from the
lower chambers. The HRP content was evaluated spectrophotome-
trically by assaying peroxidase activity in buffer containing 3.3 mM
guaiacol, 180 mM Na2HPO4 and 4.7 mM H2O2 using 96-well plates.
Absorbance was measured at 470 nm. Each experiment was
performed in quadruplicate.
2.5. PLD's adenoviral construction and virus production
Recombinant adenoviral genomes carrying the cDNA of interest
(hPLD1, hPLD2 or GFP) were generated by homologous recombination
as previously described [24]. Brieﬂy, CaCl2 competent E. coli BJ5183
was co-transformed with 200 ng of SwaI-linearized VmAdcDNA3
plasmid and 600 ng linearized pCDNA3hPLD1 or pCDNA3hPLD2. The
hPLD1b and hPLD2 cDNAs in pCDNA3 plasmids were provided by Drs were treated with (panel A) 200 U/ml bacterial scPLD, (panel B) 25 μM propranolol, or
riments. Results are expressed as fold increase comparedwith the value for control cells
te experiments performed in quadruplicate. ⁎, signiﬁcantly different from control cells,
Fig. 3. Effects of PLD overexpression on HUV-EC permeability. Panel A, HUV-EC in
35 mm culture dishes were infected with adenovirus coding for GFP (adeno-GFP),
hPLD1 (adeno-PLD1) or hPLD2 (adeno-PLD2) using a viral particles to cell number ratio
of 100, or not infected (NI). After 12 h, the viruses were washed out and cells were
further incubated in fresh culture medium for 60 h. Whole cell lysates were then
prepared, and 10 μg of proteins was subjected to Western blotting as described in
Materials and methods using anti-PLD1 or anti-PLD2 antibodies for immunodetection.
Panel B, HUV-EC cultured on Transwell ﬁlters were infected with adenovirus coding for
GFP, hPLD1 or hPLD2.12 h post-infection, mediawere replacedwith fresh ones and cells
were further incubated for 60 h. HRP was then added to the upper compartments.
Results are expressed as fold increase compared with the value for control adeno-GFP
cells, and are means±SEM of N=6 separate experiments performed in quadruplicate.
⁎, signiﬁcantly different from adeno-GFP cells, Pb0.05.
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screened by PCR with the following set of primers: A) 5′-GACGG-
ATGTGGCAAAAGTGA annealing to the leftmost part of the adenoviral
genome; and B) 5′-ATGGGGTGGAGACTTGGAAATC annealing to por-
tion of the CMV promoter, which is brought in by homologous
recombination. Positive clones were further analyzed by restriction
analysis. Positive recombinants were ampliﬁed in E. coli XL-1 blue,
digested with PacI and ﬁnally transfected by the calcium phosphate
method in HEK293 cells. Cytopathic effect due to virus productionwas
observed 8–10 days after transfection. Adenoviruses were extracted
by three freeze/thaw cycles and stored in PBS, 10% (vol/vol) glycerol
at −20 °C. Viral titer of stocks was more than 108 plaque-forming
units/ml. Infections were performed at the M.O.I. (multiplicity of
infection) 100 in complete medium. After 12 h of incubation in the
presence of viral particles, the medium was changed and cells were
cultured for 24–72 h. Under these conditions, 75% of the cells
expressed GFP.
2.6. Short interfering RNA (siRNA) synthesis and transfection
SiRNA for PLD1 (hPLD1 target sequence: AAGTTAAGAGGAAATT-
CAAGC) and siRNA for PLD2 (hPLD2 target sequence: GACA-
CAAAGTCTTGATGAG) were designed according to Fang et al. [25]
and Powner et al. [26], respectively. A siRNA without sequence
similarity with any known mammalian gene was used as a negative
control. Transfection of siRNA was performed using Xtreme Gene
reagent (Roche) with 50 nM siRNA in antibiotic-free medium. The
cells were kept for 12 h in this medium and then shifted to complete
culture medium for 48 h before treatment.
2.7. Reverse transcriptase and real-time PCR
Total RNA was isolated from HUV-EC using Trizol Reagent
(Invitrogen) according to the manufacturer's protocol. After quanti-
ﬁcation, 200 ng of total RNA was reverse transcribed in presence of
100 U Superscript II (Invitrogen) using random hexamers and oligo
(dT). Real-time PCR was performed with Fast Start DNA Master SYBR
Green kit using a LightCycler. Speciﬁc sense and antisense primers
used for ampliﬁcation were as follows:
occludin: sense: 5′-ATGTGTCTGCAGGCACACAGG; antisense: 5′-
AGGCTGCCTGAAGTCATCCAC; PLD1: sense: GGCCATCAAGATAGC-
CAAGG; antisense: AAGCGTGACAGTGAAATGG; PLD2: sense:
ACAGACTGGTGGTTGAGTCC; antisense: AGCCACTGTTGATGCCCAAG.
Data were normalized to the TATA binding protein (TBP) and
ribosomal protein (RPLPO) housekeeping gene transcripts. Data
were analyzed using LightCycler software (Roche Diagnostics).
2.8. Isolation and characterization of lipid rafts from HUV-EC
Lipid rafts were isolated according to the procedure of Diaz et al.
[27] based on the insolubility of these structures in cold non-ionic
detergent, with slightmodiﬁcations. Brieﬂy, 20–25×106 HUV-ECwere
homogenized in 1 ml of ice-cold lysis buffer (25 mM Tris, pH 7.5,
150 mM NaCl, 5 mM EDTA) supplemented with a mixture of protease
inhibitors (protease inhibitor mixture Sigma). After centrifugation at
800 g at 4 °C for 10 min, the post-nuclear supernatant was incubated
with Triton X-100 at a ﬁnal concentration of 1% for 1 h at 4 °C. The
lysate was then adjusted to 1.3 M sucrose by the addition of an equal
volume of 2.6M sucrose and placed at the bottom of an ultracentrifuge
tube, and a step sucrose gradient (0.2–0.9 M with 0.1 M steps, 1 ml
each) was placed on top. It was centrifuged at 200,000 g for 16 h in an
SW41 rotor (Kontron) at 4 °C. One-ml fractions were recovered from
the bottom to the top of the gradient. The sucrose concentration of
each fraction was determined with a Brix refractometer (Merck).
Aliquots were immediately used for 5′-nucleotidase assays, and the
remaining was stored at −20 °C until analyses.Proteins were determined by the method of Shaffner and
Weissmann [28] using BSA as a standard. Gradient protein recovery
relative to total proteins in the post-nuclear supernatant varied from
60 to 91%.
5′-Nucleotidase activity of the glycosylphosphatidylinositol-
anchored CD73, used as a marker of lipid rafts, was assayed as
described by Gentry and Olsson [29] with slight modiﬁcations.
Aliquots of the gradient fractions were incubated with 1 μM [3H]5′-
AMP in 1 ml of reaction mixture containing 60 mM Tris, pH 7.4, 1 μM
erythro-9-(2-hydroxy-3-nonyl)adenine to inhibit endogenous adeno-
sine deaminase, 20,000 cpm [14C]adenosine as an internal standard,
with or without 25 μM adenosine 5′-(α, β-methylene) diphosphate
(AMPCP) to inhibit 5′-nucleotidase activity, for 30 min at 37 °C. The
incubation was terminated by addition of 200 μl of 5% ZnSO4 and
200 μl of 0.3 M Ba(OH)2. After centrifugation, the radioactivity of
supernatant containing [3H]adenosine was measured by liquid
scintillation counting. 5′-nucleotidase activity obtained by difference
between values with and without AMPCP was expressed as nmol of
5′-AMP hydrolyzed per min per mg of proteins.
Ganglioside M1 (GM1) was quantiﬁed on dot blots according to
Diaz et al. [27]. Brieﬂy, 20 μl of each gradient fraction was dotted onto
Immobilon using a Hybri-Dot Manifold apparatus (Bethesda). Mem-
branes were rinsed with distilled water and blocked with 5% bovine
serum albumin in TBS-T for 2 h. After three 10-minwashes with TBS-T,
membranes were incubated with horseradish peroxidase-conjugated
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and then rinsed 7 times with TBS-T and developed with the ECL
reagent. The luminograms were quantiﬁed using cooled digital CCD
camera system (ImageMaster VDS-CL, GE Healthcare, France) and
Image Quant software. Results are expressed relative to the sum of the
intensity of spots present in the different gradient fractions, taken as
100.
Cholesterol was determined enzymatically using a commercial
assay kit (Sigma) according to the manufacturer's recommendations.
2.9. Western blotting experiments
2.9.1. PLD
Cells were homogenized in 20 mM Tris/HCl pH 7.6 buffer
containing 100 mM NaCl, 1% Triton, and protease inhibitors cocktail.
Cell lysates were mixed with Laemmli buffer supplemented with 2 MFig. 4. Effects of PLD downregulation on HUV-EC permeability. Panel A, HUV-EC in 35 mm cu
untreated for 8 h. Then, transfectionmediawere replacedwith fresh ones. After 48 h, cells we
PLD1 or anti-PLD2 antibodies.Membraneswere stripped and reprobedwith anti-tubulin antib
videodensitometric quantiﬁcation of PLD1 (top) and PLD2 (bottom) blots after normalization
Panel B, HUV-EC cultured on Transwell ﬁlters were transfected with 50 nM of control siRN
compartments. Results are expressed as fold increase compared with the value for control si
quadruplicate. ⁎, signiﬁcantly different from control cells, Pb0.05. Panels C andD, HUV-EC cult
with 10 μM LPA for 30 min (panel C) or 2 h (panel D) before HRP ﬂux measurement. Results
transfected cells, and are means±SEM of N=2 separate experiments performed in quadrupurea, boiled for precisely 1 min, and separated on 8% SDS
polyacrylamide gel including 4 M urea. The blots were probed with
PLD1- and PLD2-speciﬁc polyclonal antibodies kindly provided by Dr
S. Bourgoin (Laval University, Canada), diluted 1:2000. Immunoblots
were revealed with the ECL detection system and X-ray ﬁlm
autoradiography. After stripping, the membranes were reprobed
with an anti-α-tubulin monoclonal antibody for normalization.
Bands were then quantiﬁed using cooled digital CCD camera system
and Image Quant software. Protein concentrations were routinely
determined by the Bradford method [30] using BSA as a standard.
2.9.2. Gradient fractions
30 μl of gradient fractions was mixed with Laemmli buffer,
boiled for 5 min, separated on SDS PAGE and electrotransferred
on Immobilon P membrane. For immunodetection the following
primary antibodies were used: caveolin-1 (dilution 1/750), occludinlture dishes were transfected with 50 nM of control siRNA, PLD1- or PLD2-siRNA, or left
re lyzed and proteins (30 μg per well) were subjected toWestern blot analyses with anti-
ody. Blots shown (panel A, left) are representative of 3. Graphs (panel A, right) represent
byα-tubulin (N=3); ⁎, signiﬁcantly different from the three other conditions, Pb0.05.
A, PLD1- or PLD2-siRNA as described above. After 48 h, HRP was added to the upper
RNA transfected cells and are means±SEM of N=2 separate experiments performed in
ured onTranswell ﬁlterswere transfectedwith the different siRNA and stimulated or not
are expressed as fold increase compared with the value for unstimulated control siRNA
licate. ⁎, signiﬁcantly different from control unstimulated cells, Pb0.05.
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diluted 1/10,000; the anti-rabbit secondary antibody was diluted 1/
5000. Immunoreactive proteins were visualized using ECL detection
kit and X-ray ﬁlm autoradiography. For PLD1 and PLD2 WesternFig. 5. Effects of increased endogenous PA level or alteration of PLD expression on actin reo
50 μM di-C8 PA or 25 μMpropranolol were ﬁxed, permeabilized and stained for actin ﬁlamen
microscopy. Panel B, ﬂuorescence microscopy of non-infected HUV-EC (NI) or HUV-EC infecte
PLD2) after actin staining. Panel D, ﬂuorescence microscopy of cells transfected with 50 nM
Panels C and E, for each condition, the percentage of stress ﬁbre positive cells was deter
experiments. In panel C, ⁎, signiﬁcantly different from the 3 other conditions, Pb0.05. In pan
from LPA stimulated control siRNA and PLD1-siRNA transfected cells, Pb0.05.blotting, proteins from 600 μl of each fraction were precipitated with
ice-cold acetone, and pellets were dissolved in 30 μl of Laemmli buffer
containing urea (2 M ﬁnal). Bands were then quantiﬁed using cooled
digital CCD camera system and Image Quant software. Results arerganization. Panel A, HUV-EC monolayers treated for 30 min with 10 μM LPA, 1 μM S1P,
ts with rhodamine-conjugated phalloidin. Labelled cells were examined by ﬂuorescence
d with adenovirus coding for GFP (adeno-GFP), hPLD1 (adeno-PLD1) or hPLD2 (adeno-
of control siRNA, PLD1- or PLD2-siRNA and stimulated or not by 10 μM LPA for 15 min.
mined in at least 10 different ﬁelds. Similar results were obtained in N=2 separate
el E, ⁎, signiﬁcantly different from values without LPA, Pb0.05; †, signiﬁcantly different
1242 C. Zeiller et al. / Biochimica et Biophysica Acta 1793 (2009) 1236–1249expressed relative to the sum of the intensity of the corresponding
bands present in the different gradient fractions, taken as 100.
2.10. Fluorescence staining of actin ﬁlaments
HUV-EC cells stimulated with the different agonists or adenovirus
infected HUV-EC were washed, ﬁxed in 3.7% formaldehyde for 20 min
at 4 °C, permeabilized with 0.1% Triton or 50 μg/ml digitonin for
10 min at room temperature and aspeciﬁc labelling was blocked in 1%
or 0.1% BSA for 20 min. F-actin was stained with rhodamine-
conjugated phalloidin and labelled cells were examined by ﬂuores-
cence microscopy with an Axiovert 200microscope, an objective LDA-
plan, 20×/0.30 PHI ∞/40, an Axiocam MRm camera.Fig. 6. Characterization of the low-density sucrose gradient fractions prepared from contr
ﬂoatation in a discontinuous sucrose density gradient, and the fractions were analyzed for
(panel C) GM1 content. Sucrose gradient is shown in panels B and C. Results are means±S
Laemmli buffer was subjected to Western blot analysis using the corresponding primary an2.11. Immunoﬂuorescence staining of occludin
Untreated or infected cells grown on 12-well plastic plates were
preextracted with 0.1% Triton X-100 in 100 mM KCl, 3 mM MgCl2,
1 mM CaCl2, 200 mM sucrose, and 10 mMHepes (pH 7.1) for 1 min on
ice. After 2 PBS washes, cells were ﬁxed with 3.7% paraformaldehyde
for 20 min and subsequently permeabilized with 0.05% Triton X-100
for 3 min. The ﬁxed cells were blocked for 20min in PBS containing 1%
BSA. Primary anti-occludin antibody was diluted (1/25) in the same
solution and incubated with the cells overnight. After washing, cells
were incubated with Alexa-ﬂuor 546 coupled secondary mouse
antibody for 1 h. Labelled cells were examined by ﬂuorescence
microscopy.ol HUV-EC. Triton X-100 lysates prepared from control HUV-EC were fractionated by
(panel A) protein concentration and 5′-nucleotidase activity, (panel B) cholesterol and
EM of N=4 separate experiments. Panel D, 30 μl of each gradient fraction mixed with
tibodies.
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Data expressed as means±SEM were analyzed by one-way
ANOVA and means were compared by a protected t-test. Pb0.05
was considered signiﬁcant.
3. Results
3.1. PLD agonists increase endothelial permeability
We ﬁrst evaluated the effects of physiological mediators of
endothelial function on PLD activity and endothelial permeability of
HUV-EC monolayers. In agreement with previous reports [18,31] both
LPA and sphingosine 1-phosphate (S1P) increased the PLD activity of
HUV-EC monolayers, with maximal activation being obtained after
5 min of treatment. Although S1P effect was twice that of LPA at early
time points, it declined very quickly. After 30 min of treatment S1P-
stimulated PLD activity returned to basal level whereas LPA effect was
maintained throughout this period and declined thereafter (Fig. 1A).
LPA also induced a time-dependent increase in endothelial perme-
ability for horseradish peroxidase (HRP) as compared with HRP
passage through untreated cell monolayers (taken as 1 at each time
point). The LPA-induced increase in permeability lasted for several
hours, a maximal 1.7-fold increase being observed at 4 h (Fig. 1B).
After 24 h the permeability of LPA-treated monolayers did not differ
signiﬁcantly from that of untreated control monolayers. S1P treatment
of HUV-EC also increased HRP passage acrossmonolayers. As observed
for PLD activity, S1P effect was maximal earlier than LPA effect (1 h
vs 4 h) and started to decline thereafter (Fig. 1C).
3.2. Increased level of intracellular PA increases endothelial permeability
To explore further the potential role of PLD in the control of
endothelial permeability, we examined the effects of several agents
known to increase endogenous PA [14]. The addition of a bacterial PLD
from S. chromofuscus to HUV-EC monolayers maximally increased
HRP ﬂux after 1 to 2 h of treatment, suggesting that a certain lag-time
is necessary to achieve increase of PA level (Fig. 2A). In contrast,
propranolol a well-known inhibitor of PA hydrolase which has been
shown to induce endogenous PA accumulation [32,33] markedly and
rapidly increased endothelial permeability, maximal effect being
already obtained after 30 min of treatment (Fig. 2B). Finally, addition
of the cell permeant di-C8-PA induced a gradual increase in
permeability which peaked after 2 h and declined thereafter
(Fig. 2C). Similar effects were obtained with PA originating from egg
yolk (not shown).
3.3. PLD2 but not PLD1 overexpression increases basal endothelial
permeability
Results of the above experiments indicate that enhancing
endogenous PA level either through PLD activation or inhibition of
PA degradation markedly increased endothelial permeability. ToFig. 7. Effects of ﬁlipin on LPA-induced stress ﬁbre formation and endothelial
permeability. Panel A, HUV-EC monolayers were pretreated with 2 μg/ml ﬁlipin for
30 min or left untreated. Medium was then removed by aspiration and cells were
stimulated or not by 10 μM LPA. After 15 min of LPA treatment cells were stained with
rhodamine-conjugated phalloidin as described in the legend of Fig. 5. Panel B, for each
condition, the percentage of stress ﬁbre positive cells was determined in at least 10
different ﬁelds. Similar results were obtained in 2 separate experiments. Panel C, HUV-
EC cultured on Transwell ﬁlters were treated or not with 2 μg/ml ﬁlipin for 30 min.
Medium was then removed by aspiration and cells were stimulated or not with 10 μM
LPA for 2 h before HRP ﬂux measurement. Results are expressed as fold increase
compared with the value for control untreated cells, and are means±SEM of N=5
separate experiments performed in quadruplicate. ⁎, signiﬁcantly different from control
cells, Pb0.05; †, signiﬁcantly different from LPA alone, Pb0.05.
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the control of endothelial paracellular permeability, HUV-EC were
infected with adenovirus constructs containing the cDNA of hPLD1b,
or hPLD2, or GFP for control. Western blots in Fig. 3A show that the
expression level of both PLD1 and PLD2 was markedly increased in
infected cells as compared with non-infected cells or cells infected
with control GFP adenovirus. HRP ﬂux across infected HUV-EC
monolayers was measured 72 h post-infection. HUV-EC infected
with PLD2 adenovirus exhibited a sustained increase of permeability
as compared to cells infected with control GFP adenovirus. In contrast,
HRP ﬂux across PLD1 adenovirus infected HUV-EC was not signiﬁ-
cantly different from that observed with control GFP adenovirus
infected cells (Fig. 3B).
3.4. Downregulation of PLD1 and PLD2 differently affects basal and
stimulated endothelial permeability
Given the lack of isoform speciﬁc PLD inhibitors, we examined the
effect of PLD1 and PLD2 knockdown by means of speciﬁc siRNA on
endothelial permeability. As shown in Fig. 4A, both PLD1 and PLD2
siRNA reduced the level of the corresponding protein by around 70%
without affecting the other isoform. Interestingly, only PLD2 silencing
was able to reduce basal HRP ﬂux across HUV-EC monolayers
conﬁrming the prevalent role of PLD2 over PLD1 as a regulator of
basal endothelial permeability (Fig. 4B). PLD2 silencing also sup-
pressed LPA-induced short-term (30 min) increase in permeability,
whereas PLD1 silencing did not (Fig. 4C). In contrast, both PLD1 and
PLD2 silencing counteracted the stimulatory effect of LPA on HRP ﬂux
measured after 2 h of treatment, as compared with LPA effect on cells
transfected with control siRNA (Fig. 4D).
3.5. Increased level of intracellular PA induces actin stress ﬁbre formation
The stimulation of HUV-EC by both PLD agonists LPA and S1P
resulted in a rapid rearrangement of the actin network into thick
bundles of stress ﬁbres transversing the cell. Fibre formation was
detected within a few minutes (not shown) and reached a
maximum by 15–30 min (Fig. 5). They started to disappear after
30 min for S1P and 1 h for LPA (not shown). These observations
suggest that actin reorganization precedes cell contraction and cell
junction disorganization, and as a consequence, increased endothe-
lial permeability (Fig. 1B and C). PLD agonists-stimulated stress
ﬁbre formation was inhibited by the primary alcohol 1-butanol,
which decreases endogenous PA, but not by 2-butanol, an inactive
isomer (not shown). The treatment of HUV-EC by diC8-PA or
propranolol which increases endogenous PA level through inhibi-
tion of PA hydrolase [32,33] also induced actin stress ﬁbre
formation. Thus, 45±9 and 51±6% of cells treated with 50 μM
diC8-PA or 25 μM propranolol, respectively, were stress ﬁbre
positive whereas only 6±6% of untreated control cells showed
stress ﬁbres. To investigate further the possible relationships
between stress ﬁbre formation and increased endothelial perme-
ability we examined the effects of PLD overexpression on the
reorganization of actin cytoskeleton. As shown in Fig. 5B and C,Fig. 8. Effects of PLD overexpression on occludin expression and MAP kinase phosphorylatio
GFP (adeno-GFP), hPLD1 (adeno-PLD1) or hPLD2 (adeno-PLD2) using a viral particles to cell n
were further incubated in fresh culturemedium for 60 h. Panel A, whole cell lysates were then
occludin antibody. Panel B, videodensitometric quantiﬁcation of occludin blots after norma
Pb0.05. Panel C, immunoﬂuorescence labelling of occludin demonstrating loss of occludin
determined in non-infected cells and in cells infected with the various adenovirus constructs
GFP infected cells and aremeans±SEM of N=4 independent experiments. ⁎, signiﬁcantly di
anti-phospho ERK antibody for immunodetection and videodensitometric quantiﬁcation of ph
NI and adeno-GFP, Pb0.05. Panels G and H, Western blots of cell lysates using anti-phospho p
phospho-p38 MAP Kinase blots after normalization by α-tubulin (N=3); no signiﬁcant diffthe percentage of stress ﬁbre positive cells was signiﬁcantly
increased in cells infected with PLD2-adenovirus (36.7±3.7%) as
compared with non-infected cells (12.2±0.9%) or cells infected
with GFP adenovirus (11.3±1.8%). In contrast, in cells infected
with PLD1-adenovirus, the percentage of stress ﬁbre positive cells
(18.8±1.8%) did not signiﬁcantly differ from those measured in
non-infected and GFP adenovirus infected cells (Fig. 5B and C).
Interestingly, in the same experimental conditions, only PLD2
overexpression was able to signiﬁcantly increase endothelial
permeability (Fig. 3B). To more thoroughly investigate the
respective role of the two PLD isoforms in LPA-induced stress
ﬁbre formation, we examined actin cytoskeleton response to LPA
in cells transfected with control siRNA and with PLD1- or PLD2-
siRNA. Data shown in Fig. 5D and E indicate that PLD2 silencing
totally suppressed the rapid formation of stress ﬁbres in response
to LPA whereas PLD1 silencing did not prevent actin reorganization
induced by LPA.
3.6. A substantial part of PLD2 is located to the detergent insoluble
microdomains (lipid rafts) of HUV-EC
Lipid rafts were isolated from HUV-EC by fractionation of Triton
X-100 treated cell lysates on a discontinuous sucrose density
gradient. The low-density fractions containing 15 to 21% sucrose
contained speciﬁc markers of lipid rafts. Thus, about 53% of the
enzymatic activity of 5′-nucleotidase, a glycosylphosphatidylinositol
(GPI)-anchored protein [5] were recovered in the gradient fractions
6 to 8, which contained less than 4% of total proteins (Fig. 6A).
These low-density fractions were also enriched in cholesterol (about
30% of total) (Fig. 6B) and contained most part (79%) of the
ganglioside GM1 (Fig. 6C). They were further characterized by
Western blotting experiments. As shown in Fig. 6D, the gradient
fractions 6 to 8 were markedly enriched in caveolin-1 (57.2±5.8%,
N=3) and also contained part of the junctional protein occludin
which has also been found in the detergent insoluble fractions of
T84 epithelial cells [6]. In contrast, E-cadherin and claudin-1 were
not preferentially asso-ciated with the raft fractions (not shown).
Interestingly, a substantial part of PLD2 protein (42.6±1.8%, N=3)
was present in the low-density fractions of the gradient, whereas
only 16.1±4.2% (N=3) of PLD1 protein were recovered in these
raft fractions (Fig. 6D).
3.7. Disruption of lipid rafts inhibits LPA effects on stress ﬁbre formation
and endothelial permeability
To determine the importance of membrane raft integrity for stress
ﬁbre formation and increased endothelial permeability, HUV-EC were
treated with ﬁlipin (2 μg/ml), a cholesterol binding toxin, for 30 min
before LPA activation. LPA stimulated actin reorganization into thick
stress ﬁbres (Figs. 5A and 7A) and induced the formation of
paracellular gaps in the monolayer. Filipin pretreatment signiﬁcantly
prevented both of these effects (Fig. 7A and B). Indeed, only 12±2% of
cells pretreated with ﬁlipin became stress ﬁbre positive upon LPA
activation, whereas this percentage reached 32±4% in the absence ofn. HUV-EC in 35 mm culture dishes were infected with adenovirus constructs coding for
umber ratio of 100, or not infected (NI). After 12 h, the viruses werewashed out and cells
prepared, and equal amounts of proteinswere subjected toWestern blotting using anti-
lization by α-tubulin (N=4); ⁎, signiﬁcantly different from the three other conditions,
at cell periphery in PLD2 overexpressing cells. Panel D, occludin mRNA levels were
by quantitative real-time PCR. Data are expressed as fold change compared with adeno-
fferent fromNI and adeno-GFP, Pb0.05. Panels E and F, Western blots of cell lysates using
ospho-ERK blots after normalization byα-tubulin (N=5); ⁎, signiﬁcantly different from
38MAP kinase antibody for immunodetection and videodensitometric quantiﬁcation of
erences.
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endothelial permeability (Fig. 7C). Altogether, these results indicate
that raft integrity is necessary for maintaining actin dynamics, andsuggest that PLD2 effects on stress ﬁbre formation and endothelial
permeability that we observed in the present study might be related
to the preferential location of the enzyme in raft domains.
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expression
Occludin plays a critical role in regulating the barrier function of
endothelial monolayers. Indeed, the loss of occludin at endothelial
junctions induced by VEGF treatment has been associated with an
increased permeability of endothelial monolayers through a signaling
pathway involving mitogen-activated protein (MAP) kinases [34].
Given the results of the present study showing that PLD2 over-
expression increased HRP ﬂux through HUV-EC monolayers (Fig. 3),
we then compared the level of occludin expression in cells infected by
the different adenovirus constructs. Western blotting experiments
shown in Fig. 8A and B, indicate that occludin level was signiﬁcantly
decreased in cells overexpressing PLD2, as compared with non-
infected cells or cells infected by the other adenovirus constructs. Such
downregulation was accompanied by a loss of occludin protein
expression at cell periphery (Fig. 8C) and was conﬁrmed by a
signiﬁcant decrease of occludin mRNA levels (Fig. 8D). Concomitantly
with changes in occludin expression, an increased level of phos-
phorylated ERK (Fig. 8E and F) was also observed, whereas the level of
phosphorylated p38 MAP kinase was not altered (Fig. 8G and H). In
contrast, PLD1 overexpression did not induce signiﬁcant changes in
occludin expression level or ERK phosphorylation. These results show
that PLD2 overexpression downregulates occludin and stimulates the
MEK/ERK pathway, thus suggesting a possible link between both
events, as it has been demonstrated in epithelial cells [35]. Indeed,
transient transfection of Pa-4 epithelial cells with a constitutively
active form of MEK1 drastically reduced occludin mRNA level, such
downregulation being blocked by the MEK inhibitor PD98059 [35].
3.9. Activation of ERK1/2 by Raf-1 is required for PA-mediated increase
of endothelial permeability
The MAP kinase pathway is known to mediate an elevation of
endothelial permeability [36]. To examine whether the MAP kinase
cascade was involved in PA-induced hyperpermeability, HUV-EC were
pretreated with the MEK inhibitors PD98059 and U-0126 before
stimulation of cells with LPA. These compounds have been shown to
prevent the activation of ERK1/2 and the subsequent phosphorylation
of ERK1/2 substrates both in acellular systems and in intact cells
[37,38]. As shown in Fig. 9A, pretreatment of HUV-EC with the MEK
inhibitors signiﬁcantly reduced the elevation of permeability induced
by LPA. Furthermore, Raf-1, a serine/threonine kinase which directly
activates MEK and the MAP kinase cascade is a well-known target of
PA. Raf-1 is activated through translocation to PA-enriched domains of
plasma membrane driven by the ligation of PA to a speciﬁc domain of
the protein, and interaction with Ras [39]. To examine whether Raf-1
was involved in the PA-induced hyperpermeability, we used a
selective Raf-1 kinase inhibitor, GW-5074 [40]. GW-5074 signiﬁcantly
attenuated LPA and PA-induced hyperpermeability (Fig. 9B and C).
Moreover, GW-5074 suppressed hyperpermeability induced by PLD2
overexpression without altering the permeability of PLD1- or GFP-Fig. 9. Raf-1 mediates PA-induced ERK-1/2 activation and hyperpermeability. Panel A, HUV
10 μMU0126 during 30 min and cells were stimulated or not with 10 μM LPA for 2 h before HR
control cells and are means±SEM of N=3 separate experiments performed in quadruplicat
stimulatedwith LPA alone. Panel B, HUV-EC cultured onTranswell ﬁlters were pretreated or n
for 2 h before HRP ﬂuxmeasurement. Results are expressed as fold increase compared with th
in quadruplicate. ⁎, signiﬁcantly different from control cells, Pb0.05; †, signiﬁcantly different
pretreated or not with 100 nM GW-5074 for 30 min and cells were treated with 50 μM diC
Pb0.05; †, signiﬁcantly different from cells stimulatedwith PA alone. Panel D, HUV-EC culture
hPLD2 in the presence or absence of 100 nM GW-5074. 12 h post-infection, media were rep
measured 2 h after HRP addition to the upper compartment. Results are expressed as fold i
N=4 separate experiments performed in triplicate. ⁎, signiﬁcantly different from adeno
GW-5074. Panels E and F, HUV-ECwere pretreated or notwith 100 nMGW-5074 for 30min an
15min (panel F). Cell lysates were subjected toWestern blotting using anti-phospho-ERK ant
anti-tubulin antibody (bottom). Panel G and H, videodensitometric quantiﬁcation of phosp
control cells, Pb0.05; †, signiﬁcantly different from cells stimulated with LPA (panel G) or doverexpressing cells (Fig. 9D). Western blotting experiments show
that ERK1/2 was activated by PA and LPA (Fig. 9E–H). Pretreatment of
HUV-EC for 30 min with 100 nM GW-5074 reduced LPA and PA-
induced ERK-1/2 phosphorylation (Fig. 9E–H). Altogether, these data
show that Raf and ERK1/2 are downstream effectors of PA and are
necessary for PA-induced hyperpermeability.
4. Discussion
The barrier function of vascular endothelium is a highly regulated
process involving intricate signaling cascades [2]. Any dysfunction of
this barrier may lead to pathological situations including inﬂamma-
tion and atherosclerosis. PLD and PLD-generated PA have been
implicated in the increased permeability induced by ROS and pro-
oxidant compounds, especially in bovine pulmonary arteries [14].
However the signaling pathways downstream of PLD leading to
endothelium permeability changes have not been clearly deﬁned. In
the present study we used a variety of approaches to increase the
intracellular PA and to establish potential links between elevation of
PA level, cytoskeleton rearrangements, tight-junction disturbance and
increased endothelial permeability. We ﬁrst used two agonists of
lysophospholipid receptors, LPA and S1P [41], both of them having
been shown to stimulate PLD activity in some types of cells. Indeed,
LPA has been described as a PLD activator in ﬁbroblasts [16],
endothelial cells [18], epithelial cells [19], prostate cancer cells [42]
or human neutrophils [43], whereas S1P-induced PLD activation has
been reported in ﬁbroblasts [44], bronchial epithelial cells [45] or
pulmonary endothelial cells [46]. Both LPA and S1P have been shown
to either increase or decrease monolayer permeability depending on
the endothelial cell type considered. There are four LPA receptors and
ﬁve S1P receptors identiﬁed in mammals to date [41]. They are
coupled to a variety of downstream signaling cascades through
different classes of G proteins including Gi, Gq, G12/13. Whereas
coupling through G12/13 activates exclusively the RhoA pathway
leading to stress ﬁbre formation and increased permeability due to
cell retraction and intercellular gap formation, coupling through Gi
activates both Rac and RhoA. Unlike RhoA, Rac activation induces
cortical actin formation, assembly of adherens junctions and improves
endothelial barrier function [47,48]. Thus, the ﬁnal outcome of LPA
and S1P action on vascular permeability may be determined by the
balance between RhoA and Rac activation depending on the type of
endothelial cell considered. In the HUV-EC line used in the present
study both LPA and S1P stimulated PLD activity, induced transient
stress ﬁbre formation and increased endothelial permeability, thus
suggesting the prevalence of RhoA-dependent signaling pathways.
Besides LPA and S1P, we used different treatments to increase PA
intracellular level, namely exogenous dioctanoyl PA, propranolol and
bacterial scPLD. Dioctanoyl PA, a cell permeant compound, has been
shown to exert effects similar to those obtained with PLD-generated
PA in various cell models [49]. Propranolol, a well-known inhibitor of
PA phosphohydrolase has been shown to increase PA levels in many
types of intact cells including smooth muscle cells [50] or L6-EC cultured on Transwell ﬁlters were pretreated or not with 25 μM PD98059 or with
P ﬂuxmeasurement. Results are expressed as fold increase comparedwith the value for
e. ⁎, signiﬁcantly different from control cells, Pb0.05; †, signiﬁcantly different from cells
ot with 100 nMGW-5074 during 30min and cells were stimulated or notwith 10 μMLPA
e value for control cells and aremeans±SEM of N=2 separate experiments performed
from cells stimulated with LPA alone. Panel C, HUV-EC cultured on Transwell ﬁlters were
8-PA for 2 h before HRP ﬂux measurement. ⁎, signiﬁcantly different from control cells,
d on Transwell ﬁlters were infectedwith adenovirus constructs coding for GFP, hPLD1 or
laced with fresh ones and cells were further incubated for 60 h. HRP permeability was
ncrease compared with the value for control adeno-GFP cells, and are means±SEM of
-GFP cells, Pb0.05; †, signiﬁcantly different from adeno-PLD2 cells cultured without
d then stimulated or notwith 10 μMLPA for 30min (panel E), or with 50 μMdiC8-PA for
ibody for immunodetection (top). The samemembranewas stripped and reprobedwith
ho-ERK blots after normalization by α-tubulin (N=3). ⁎, signiﬁcantly different from
iC8-PA (panel H) alone, Pb0.05.
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used to induce PA synthesis in membranes of living cells to mimic the
effects of endogenous mammalian PLD. In addition, this bacterial
enzyme also possesses lysoPLD activity and is able to catalyze the
synthesis of LPA from LPC [51], both activities leading to increased PA
level either directly or through LPA-induced endogenous PLDactivation. The three agents used to enhance intracellular PA level
increased HRP ﬂux through endothelial monolayers and induced the
formation of stress ﬁbre bundles. The effect of PLD activation on
cytoskeleton reorganization has been proposed to be due to the ability
of PA to bind and activate the PI4P 5-kinase leading to an increased
level of PI4,5P2 [52]. PI4,5P2 is known to interact with several actin
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the formation of actin bundles [53].
It is well-recognized that actin polymerization is a Rho-dependent
process [54]. One of the best characterized targets of RhoA is the p160
Rho kinase which phosphorylates the myosin light chains (MLC)
directly and also inhibits MLC dephosphorylation. The resulting
increase of MLC phosphorylation level contributes to actin stress
ﬁbre formation and increased actomyosin contractility [54]. RhoA is
also a well-known PLD activator [8]. Thus, it is conceivable that the
RhoA-stimulated PA synthesis also contributes to stress ﬁbre
accumulation. However, RhoA selectively activates the PLD1 isoform
whereas PLD2 is not sensitive to RhoA regulation [8]. In our cell model,
overexpressing PLD2 increased basal permeability (Fig. 3B), possibly
due to the formation of stable stress ﬁbres (Fig. 5B), and also through
decreased expression of occludin and disturbance of intercellular
junctions resulting from occludin loss (Fig. 8C). PLD2 thus seems to
regulate basal endothelial permeability, as conﬁrmed by the effect of
PLD2 depletion which reduced basal permeability (Fig. 4B). On the
contrary, based on overexpression experiment (Fig. 3B), PLD1 does
not seem to regulate basal endothelial permeability. This might be
linked with the fact that overexpression of PLD1 induces by itself only
a weak formation of stable stress ﬁbres (Fig. 5B), and does not
inﬂuence occludin expression and pericellular location (Fig. 8C). This
is in agreement with the inability of PLD1 depletion to reduce basal
permeability (Fig. 4B).
It must be noticed that PLD1 activity under basal conditions, due to
its much lower speciﬁc activity [55] and lower level of expression in
HUV-EC cells (2-fold as evaluated by real-time qPCR experiments,
results not shown) as compared with PLD2, represents only a minor
part of total PLD activity, andmight thus play a negligible role. Instead,
in LPA-stimulation conditions, PLD1 is likely to be activated [19] in
particular via RhoA, and the contribution of PLD1 activity may become
important. We indeed observed that PLD2-si RNA had a strong
inhibitory effect on basal PLD activity, whereas PLD1-siRNA had no
effect. Furthermore, PLD2-siRNA and PLD1-siRNA similarly inhibited
LPA stimulated PLD activity (not shown). Accordingly, PLD1 depletion,
as well as PLD2 depletion, decreased the permeability measured after
long term (2 h) LPA treatment, suggesting that both PLD isoforms are
necessary for LPA to increase permeability (Fig. 4D).
Surprisingly, only PLD2 depletion strongly prevented rapid LPA-
induced stress ﬁbre formation while PLD1 depletion had no effect
(Fig. 5D and E), suggesting that stress ﬁbres play little role in the
increase in permeability induced by LPA. However, since the
observation of stress ﬁbres was performed after a short treatment
by LPA (15 min), whereas the suppression of permeability increase by
PLD1- and PLD2-siRNAs was observed after 2 h of LPA treatment
(when LPA-induced stress ﬁbres have subsided), it is possible that
only the short-term increase in permeability induced by LPA (0.5–1 h,
Fig. 1B) was caused by transient stress ﬁbre formation and cell
retraction, and is thus dependent on the sole PLD2. In support to this,
when permeability was measured after a short treatment by LPA
(30 min), only PLD2 depletion signiﬁcantly affected permeability,
PLD1 depletion having no signiﬁcant effect (Fig. 4C). Instead, the
delayed increase in permeability induced by LPA (≥2 h), could be
independent of transient stress ﬁbres and necessitate both PLD1 and
PLD2. In this regard, it has been claimed by several authors that PLD1
could be regulating PLD2, possibly through the production of PI4,5P2
[56,57]. PLD2might thus be the key player in endothelial permeability
regulation, with PLD1 playing an accessory role. The observation that
PLD1 and PLD2 isoforms differently affect basal cell functions has been
made in other cell models. For example, Padron et al. [58] have shown
that only PLD2 silencing reduced the recycling of transferrin receptors
in HeLa cells, whereas siRNA against PLD1 had no effect.
The difference of effect between PLD1 and PLD2 on endothelial
permeability might also be related to their different subcellular
localization. Our fractionation experiments showed that the propor-tion of PLD2 protein present in the low-density fractions of the
gradient enriched in speciﬁc markers of raft structures and caveolin
was about 2.7-fold higher than that of PLD1 (Fig. 6). Interestingly,
PLD2 has been described as the only PLD isoform present in lipid
microdomains of primary cultured HUV-EC [10]. Results of the present
study showed that the integrity of raft structures/caveolae is a
prerequisite for LPA effect on endothelial permeability. Indeed,
pretreatment of HUV-EC with the cholesterol-sequestering agent
ﬁlipin abrogated both actin stress ﬁbre formation and increased HRP
ﬂux induced by LPA activation (Fig. 7). In bovine aortic endothelial
cells, the formation of stress ﬁbres induced by thrombin was only
dependent on raft integrity because it was suppressed by ﬁlipin but
not by caveolae disorganization through caveolin depletion [59].
Because cholesterol sequestration alters both membrane rafts and
caveolae, we cannot associate LPA effect, and thus PLD activation, to
one or the other structure.
Besides cytoskeleton reorganization and cell contraction, inter-
endothelial junctions, and among them tight junctions, represent
another major device regulating endothelial permeability [2]. It has
been shown that the quality of the endothelial barrier is directly
correlated to the level of occludin expression [34]. Furthermore the
loss of occludin at endothelial and epithelial junctions appears to
result from a Raf-1-dependent activation of MAP kinase signal
transduction cascade [60,61]. In the present study, we observed that
PLD2 overexpression induced a signiﬁcant decrease of occludin
expression at cell periphery. Downregulation of both occludin protein
and mRNA was accompanied by a signiﬁcant ERK1/2 activation
evaluated by the level of phosphorylated ERK1/2 proteins. Unlike
ERK1/2, p38 MAP kinase phosphorylation level was not modiﬁed by
PLD2 overexpression. Because Raf-1 kinase is a well-known target of
PA [39], we further investigated whether Raf-1 kinase/MAP kinase
were involved in the signaling pathway leading from PLD activation to
increased permeability. We showed that the Raf kinase inhibitor GW-
5074 was able to drastically reduce hyperpermeability induced by
PLD2 overexpression. GW-5074 also inhibited the PA- and LPA-
induced increase in endothelial permeability and ERK1/2 phosphor-
ylation level, suggesting that hyperpermeability resulting from PA
accumulation involved the sequential activation of Raf-1 and ERK1/2.
It has been recently demonstrated that activation of the Raf/MEK/
ERK1/2 pathway induces the upregulation of the transcriptional
repressor Slug, which in turn inhibits occludin expression through
interaction with the occludin promoter [60]. On the other hand, it is
also known that MAP kinase activation can rapidly induce hyperper-
meability through occludin displacement from tight junctions [61].
Thus, we propose that activation of the Raf/MEK/ERK1/2 pathway by
increased PA intracellular level has both fast and long term effects on
endothelial permeability, through tight-junction regulation.
On the whole, the present results demonstrate the selective role of
PLD2 isoform in the control of endothelial permeability, through a
mechanism involving both stress ﬁbre formation and contraction, and
occludin displacement and downregulation subsequent to PA-
mediated activation of Raf-1 and its downstream targets MEK-1 and
ERK1/2.
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